Comments

Ensysce Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Ensysce Biosciences (ENSC) operate in?

Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ENSCNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.55

0.218.97%

At close: -

$2.47

-0.08-3.14%

After Hours: 7:58 PM EDT

Q1 2025 Earnings were released on Tue May 13th, after the market close

Ensysce Biosciences (ENSC) Forecast

News Earnings Ensysce Biosciences (ENSC) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC | Benzinga

Explore Ensysce Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ENSC.

Open	$2.26
Close	$2.55
Volume / Avg.	216.85K / 1.64M
Day Range	$2.26 - $2.60
52 Wk Range	1.62 - 14.67
Market Cap	$4.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	8.93%
Days to Cover	1

Recent News

Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why

Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.

Vandana Singh

Crude Oil Falls Over 3%; Philip Morris Earnings Top Views

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.26
Close	$2.55
Volume / Avg.	216.85K / 1.64M
Day Range	$2.26 - $2.60
52 Wk Range	1.62 - 14.67
Market Cap	$4.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	8.93%
Days to Cover	1

About Ensysce Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platfor...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ensysce Biosciences (ENSC) stock?

You can purchase shares of Ensysce Biosciences (NASDAQ:ENSC) through any online brokerage.

View our list of the best stock brokerages

Who are Ensysce Biosciences (ENSC) competitors?

Other companies in Ensysce Biosciences’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Synaptogenix (NASDAQ:SNPX) and Palisade Bio (NASDAQ:PALI).

What is the forecast, or price target, for Ensysce Biosciences (ENSC) stock?

Ensysce Biosciences has a consensus price target of $7.50.

What is the current price for Ensysce Biosciences (ENSC)?

The stock price for Ensysce Biosciences (NASDAQ: ENSC) is $2.47 last updated May 19, 2025 at 7:58 PM EDT.

Does Ensysce Biosciences (ENSC) pay a dividend?

There are no upcoming dividends for Ensysce Biosciences.

When is Ensysce Biosciences (NASDAQ:ENSC) reporting earnings?

Ensysce Biosciences’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Ensysce Biosciences (ENSC) going to split?

There is no upcoming split for Ensysce Biosciences.

What sector and industry does Ensysce Biosciences (ENSC) operate in?

Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.